What anticholinergic medications can cause increased sexual expressions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Anticholinergic Medications and Increased Sexual Expression

The evidence does not support that anticholinergic medications cause increased sexual expressions; rather, anticholinergics are consistently associated with sexual dysfunction, including decreased libido and impaired arousal. 1

Anticholinergics and Sexual Dysfunction

Anticholinergic medications typically cause sexual dysfunction, not increased sexual activity. The mechanism involves broad muscarinic receptor blockade that negatively affects multiple physiological systems, including sexual function. 1

Common Anticholinergic Medications That Cause Sexual Problems:

  • Overactive bladder agents (e.g., oxybutynin, trospium, solifenacin) are strongly anticholinergic and poorly tolerated in many patients, though one small study in women with MS showed no significant impact on sexual function measures. 1, 2

  • Older antihistamines (e.g., diphenhydramine, hydroxyzine) have strong anticholinergic effects that contribute to overall anticholinergic burden. 1

  • Muscle relaxants (e.g., cyclobenzaprine) possess strong anticholinergic properties that affect cognition and functionality. 1

  • Antipsychotic medications with anticholinergic properties are associated with sexual dysfunction, hyperprolactinemia, and decreased libido—not increased sexual expression. 1, 3, 4

Important Clinical Distinction

When antipsychotics are used, anticholinergic agents are often prescribed to manage extrapyramidal side effects, which further increases anticholinergic burden and worsens sexual dysfunction. 1 This combination therapy is associated with increased rates of sexual dysfunction, not increased sexual expression. 1

Anticholinergic Burden Effects:

  • "Anticholinergic burden" from multiple anticholinergic drugs adversely affects cognition, functional status, and activities of daily living scores. 1

  • The Drug Burden Index demonstrates that sedating or strongly anticholinergic medications are associated with decline in cognition and functional status. 1

  • Anticholinergic effects include vision problems, urinary retention, constipation, and cognitive impairment—all of which would impair rather than enhance sexual function. 1

Medications That May Increase Libido

If you are looking for medications that can paradoxically increase sexual expression, consider:

  • Donepezil (an acetylcholinesterase inhibitor—the opposite of anticholinergic) has been reported in case reports to cause increased libido, with resolution upon withdrawal and recurrence upon reintroduction. 5

  • Some antiepileptic drugs like oxcarbazepine, lamotrigine, and levetiracetam may improve sexual function, though these are not anticholinergics. 6

Clinical Pitfall to Avoid

Do not confuse disinhibited sexual behavior in dementia or psychiatric conditions with medication-induced increased libido. Inappropriate sexual expressions in patients with dementia or psychosis are typically manifestations of the underlying disease process, not anticholinergic medication effects. 5 In fact, anticholinergic medications used to treat these conditions typically worsen cognitive function and would not be expected to increase sexual expression. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Anticholinergics do not affect the sexual function in women diagnosed with multiple sclerosis].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2016

Research

Increased libido associated with donepezil treatment: a case report.

Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.